MDxHealth SA (MDXH:NASDAQ) closed at $0.183 on October 19, 2026, down 11.33% on the day. The stock trades 96.6% below its 52-week high of $5.33 and 7.1% above its 52-week low of $0.171. Over the past year, it lost 95.6%. MDxHealth SA is part of the Health Care sector.
In 252 trading sessions since October 17, 2025, MDXH closed higher on 95 days (38%). Its best day was August 14, 2026 (+74.89%) and its worst was October 16, 2026 (-65.73%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
Find more stocks like MDXH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.